SEC Form 5
FORM 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response: 1.0
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Form 3 Holdings Reported.
X
Form 4 Transactions Reported.
1. Name and Address of Reporting Person*
Ross Julian T

(Last) (First) (Middle)
C/O 10880 JOHN W. ELLIOT DRIVE
SUITE 600

(Street)
FRISCO TX 75033

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OxySure Systems Inc [ OXYS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO, PRESIDENT, CFO, SECRETARY
3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2011
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Amount (A) or (D) Price
Common Stock 12,800,000 I Held by JTR Investments, Limited
Common Stock 400,000 I Held by The Ross Family Trust u/t/a Dated December 1999
Common Stock 8,000 I Held by spouse
Common Stock 335,880 I Held by Afritex Medical Products (Pty) Ltd.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants $0.01 12/31/2008 12/31/2013 Common Shares 116,667 116,667 I Held by JTR Investments, Limited
Warrants $0.01 12/31/2008 12/31/2013 Common Shares 163,818 163,818 I Held by JTR Investments, Limited
Warrants $0.01 06/30/2009 06/30/2014 Common Shares 48,358 48,358 I Held by JTR Investments, Limited
Warrants $0.01 12/31/2009 12/31/2014 Common Shares 52,640 52,640 I Held by JTR Investments, Limited
Warrants $0.01 03/31/2011 03/31/2016 Common Shares 42,872 42,872 I Held by JTR Investments, Limited
Warrants $0.01 06/30/2011 06/30/2016 Common Shares 107,811 107,811 I Held by JTR Investments, Limited
Warrants $2.5 03/26/2010 03/26/2016 Common Shares 270,000 270,000 I Held by Afritex Medical Products (Pty) Ltd.
Warrants $0.01 09/30/2011(1) 4A 35,006 09/30/2011 09/30/2016 Common Shares 35,006 $0 35,006 I Held by JTR Investments, Limited
Warrants $0.01 12/31/2011(1) 4A 21,000 12/31/2011 12/31/2016 Common Shares 21,000 $0 21,000 I Held by JTR Investments, Limited
Options (Right to buy) $0.25 01/15/2005 01/15/2015 Common Shares 108,962 108,962 D
Options (Right to buy) $0.25 01/15/2006 01/15/2016 Common Shares 180,000 180,000 D
Options (Right to buy) $0.25 01/15/2007 01/15/2017 Common Shares 180,000 180,000 D
Options (Right to buy) $0.25 01/15/2008 01/15/2018 Common Shares 180,000 180,000 D
Options (Right to buy) $0.25 01/15/2009 01/15/2019 Common Shares 180,000 180,000 D
Options (Right to buy) $0.25 01/15/2010 01/15/2020 Common Shares 180,000 180,000 D
Options (Right to buy) $0.25 01/15/2011 01/15/2021 Common Shares 180,000 180,000 D
Options (Right to buy) $0.25 01/15/2011(2) 4A 30,000(2) 10/15/2011 10/15/2021 Common Shares 165,000 $0 165,000 D
Options (Right to buy) $0.72 03/01/2005 03/01/2015 Common Shares 16,500 16,500 I Held by spouse
Options (Right to buy) $0.72 03/01/2006 03/01/2016 Common Shares 20,000 20,000 I Held by spouse
Options (Right to buy) $0.72 03/01/2007 03/01/2017 Common Shares 12,500 12,500 I Held by spouse
Options (Right to buy) $0.72 03/01/2008 03/01/2018 Common Shares 7,500 7,500 I Held by spouse
Options (Right to buy) $0.72 03/01/2009 03/01/2019 Common Shares 5,000 5,000 I Held by spouse
Options (Right to buy) $1 03/01/2010 03/01/2015 Common Shares 10,000 10,000 I Held by spouse
Options (Right to buy) $1 03/01/2011 03/01/2016 Common Shares 10,000 10,000 I Held by spouse
Warrants $0.01 09/30/2008 09/30/2013 Common Shares 7,000 7,000 I Held by spouse
Convertible Securities $1.5 03/01/2008 04/15/2013(3) Common Shares 166,667 166,667 I Held by JTR Investments, Limited
Convertible Securities $1.5 12/31/2008 (4) Common Shares 220,700 220,700 I Held by JTR Investments, Limited.
Convertible Securities $1.5 06/30/2009 (4) Common Shares 77,233 77,233 I Held by JTR Investments, Limited
Convertible Securities $1.5 12/31/2009 (4) Common Shares 61,200 61,200 I Held by JTR Investments, Limited
Convertible Securities $1.5 03/31/2010 (4) Common Shares 30,000 30,000 I Held by JTR Investments, Limited
Explanation of Responses:
1. Acquired in routine quarterly acquisitions pursuant to the terms of that certain JTR Senior Note dated November 1, 2008 (as modified on March 30, 2011).
2. Automatic vesting of stock options previously issued. 15,000 options vested on 11/15/2011 and 15,000 options vested on 12/15/2011.
3. Modified maturity date of this subordinated convertible promissory note, per that certain modification dated November 14, 2011.
4. Demand notes.
/s/ Julian T. Ross 02/10/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.